NICE rejects AbbVie leukemia drug over price

NICE gave a negative opinion on AbbVie ’s Venclyxta in combination with Roche’s Rituxan, for treating relapsed or refractory chronic lymphocytic leukaemia in adults.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news